MX2007008723A - Polipeptidos de yersinia spp y metodos de uso. - Google Patents
Polipeptidos de yersinia spp y metodos de uso.Info
- Publication number
- MX2007008723A MX2007008723A MX2007008723A MX2007008723A MX2007008723A MX 2007008723 A MX2007008723 A MX 2007008723A MX 2007008723 A MX2007008723 A MX 2007008723A MX 2007008723 A MX2007008723 A MX 2007008723A MX 2007008723 A MX2007008723 A MX 2007008723A
- Authority
- MX
- Mexico
- Prior art keywords
- polypeptides
- methods
- yersinia spp
- yersinia
- spp
- Prior art date
Links
- 229920001184 polypeptide Polymers 0.000 title abstract 4
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 241000607734 Yersinia <bacteria> Species 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0291—Yersinia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
- C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US64610605P | 2005-01-21 | 2005-01-21 | |
| PCT/US2006/002474 WO2006079076A2 (en) | 2005-01-21 | 2006-01-20 | Yersinia spp. polypeptides and methods of use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2007008723A true MX2007008723A (es) | 2007-09-12 |
Family
ID=36649588
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2007008723A MX2007008723A (es) | 2005-01-21 | 2006-01-20 | Polipeptidos de yersinia spp y metodos de uso. |
Country Status (12)
| Country | Link |
|---|---|
| US (8) | US8563004B2 (enExample) |
| EP (3) | EP1848732B1 (enExample) |
| JP (3) | JP2008528512A (enExample) |
| CN (1) | CN101142230A (enExample) |
| AU (1) | AU2006206234B2 (enExample) |
| BR (1) | BRPI0606506A2 (enExample) |
| CA (1) | CA2595163A1 (enExample) |
| DK (1) | DK1848732T3 (enExample) |
| ES (1) | ES2588010T3 (enExample) |
| MX (1) | MX2007008723A (enExample) |
| NZ (1) | NZ556651A (enExample) |
| WO (1) | WO2006079076A2 (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5830479A (en) * | 1994-02-09 | 1998-11-03 | Willmar Poultry Company, Inc. | Active immunization using a siderophore receptor protein |
| DE69535374T2 (de) * | 1994-02-09 | 2007-08-23 | Epitopix Llc, Willmar | Aktive immunisierung gegen ein siderophores rezeptorprotein |
| EP1353689B9 (en) * | 2001-01-03 | 2006-06-28 | Epitopix LLC | Immunizing compositions and methods of use |
| WO2005028665A2 (en) | 2003-09-19 | 2005-03-31 | Epitopix, Llc | Campylobacter polypeptides and methods of use |
| EP1848732B1 (en) | 2005-01-21 | 2016-07-27 | Epitopix, LLC | Yersinia spp. polypeptides and methods of use |
| KR101920541B1 (ko) * | 2011-05-31 | 2018-11-20 | 허치슨 바이오필름 메디컬 솔루션스 리미티드 | 세포 응집물의 분산 및 분리 |
| US9631221B1 (en) * | 2011-09-02 | 2017-04-25 | Becton, Dickinson And Company | Identification of microorganisms using MALDI-TOF-MS on-plate extraction |
| JP5828461B2 (ja) | 2011-12-29 | 2015-12-09 | Ｔａｏヘルスライフファーマ株式会社 | アミロスフェロイドが結合して成熟神経細胞死を誘発する標的分子、アミロスフェロイドが誘導する神経細胞死を抑制する方法及び物質、及びそれらの利用 |
| EP2816110B1 (en) * | 2012-02-13 | 2018-11-28 | National University Corporation Kyoto Institute of Technology | Peptide having affinity for silicon nitride (si3n4), and use therefor |
| US8753643B1 (en) | 2012-04-11 | 2014-06-17 | Life-Science Innovations, Llc | Spray dried compositions and methods of use |
| US9017953B2 (en) * | 2012-05-18 | 2015-04-28 | Washington University | Biomarker and therapeutic for urinary tract infection |
| RU2549712C1 (ru) * | 2013-11-26 | 2015-04-27 | Федеральное казенное учреждение здравоохранения "Ростовский-на-Дону ордена Трудового Красного Знамени научно-исследовательский противочумный институт" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека | CПОСОБ ВЫДЕЛЕНИЯ ИНГИБИТОРА СЕКРЕЦИИ СИДЕРОФОРОВ, СИНТЕЗИРУЕМОГО pgm- ШТАММАМИ Y. pestis И ВЫДЕЛЕННЫЙ ИНГИБИТОР |
| FR3024903A1 (fr) * | 2014-08-14 | 2016-02-19 | Biomerieux Sa | Procede de quantification d'au moins un groupe de microorganismes par spectrometrie de masse |
| US11345977B2 (en) * | 2014-10-10 | 2022-05-31 | Rare Element Resources Ltd. | Processing for the extraction of rare earth elements |
| IL284430B2 (en) | 2015-01-20 | 2024-04-01 | Igm Biosciences Inc | Tumor necrosis factor-α receptor binding molecules and their uses |
| US11235049B2 (en) | 2015-11-09 | 2022-02-01 | Epitopix, Llc | Polypeptides of fusobacterium and methods of use |
| US10166280B2 (en) | 2016-06-08 | 2019-01-01 | Epitopix, Llc | Polypeptides and immunizing compositions containing Bacillus polypeptides and methods of use |
| JP7183168B2 (ja) | 2017-02-10 | 2022-12-05 | エピトピックス， エルエルシー | タンパク質、及びＰａｓｔｅｕｒｅｌｌａタンパク質を含有する免疫化組成物、ならびに使用方法 |
| US12350337B2 (en) | 2019-10-18 | 2025-07-08 | University Of Utah Research Foundation | Polymeric drug delivery conjugates and methods of making and using thereof |
| CN113679829B (zh) * | 2020-05-18 | 2024-01-02 | 北京繁易纳维科技有限公司 | 一种预防癌症术后复发的肿瘤疫苗及其制备方法和应用 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5420253A (en) * | 1993-09-09 | 1995-05-30 | Willmar Poultry Company, Inc. | Method for purifying egg yolk immunoglobulins |
| US5830479A (en) | 1994-02-09 | 1998-11-03 | Willmar Poultry Company, Inc. | Active immunization using a siderophore receptor protein |
| DE69535374T2 (de) * | 1994-02-09 | 2007-08-23 | Epitopix Llc, Willmar | Aktive immunisierung gegen ein siderophores rezeptorprotein |
| JPH09505085A (ja) * | 1994-03-22 | 1997-05-20 | ファイザー インク． | パスツレラ科抗原および関連ワクチン |
| US5538733A (en) * | 1994-07-07 | 1996-07-23 | Willmar Poultry Company, Inc. | Method of priming an immune response in a one-day old animal |
| WO1998024912A2 (en) * | 1996-12-04 | 1998-06-11 | Heska Corporation | Recombinant plague vaccine |
| US6248329B1 (en) * | 1998-06-01 | 2001-06-19 | Ramaswamy Chandrashekar | Parasitic helminth cuticlin nucleic acid molecules and uses thereof |
| US6610836B1 (en) * | 1999-01-29 | 2003-08-26 | Genome Therapeutics Corporation | Nucleic acid amino acid sequences relating to Klebsiella pneumoniae for diagnostics and therapeutics |
| US6682754B2 (en) | 1999-11-24 | 2004-01-27 | Willmar Poultry Company, Inc. | Ovo delivery of an immunogen containing implant |
| US20020061569A1 (en) | 2000-03-21 | 2002-05-23 | Robert Haselbeck | Identification of essential genes in prokaryotes |
| EP1353689B9 (en) * | 2001-01-03 | 2006-06-28 | Epitopix LLC | Immunizing compositions and methods of use |
| AT410798B (de) | 2001-01-26 | 2003-07-25 | Cistem Biotechnologies Gmbh | Verfahren zur identifizierung, isolierung und herstellung von antigenen gegen ein spezifisches pathogen |
| GB0127657D0 (en) * | 2001-11-19 | 2002-01-09 | Microscience Ltd | Virulence genes and proteins and their use |
| DK2255826T3 (en) | 2002-08-02 | 2016-06-20 | Glaxosmithkline Biologicals Sa | Neisserial vaccine compositions comprising a combination of antigens. |
| WO2005028665A2 (en) * | 2003-09-19 | 2005-03-31 | Epitopix, Llc | Campylobacter polypeptides and methods of use |
| CA2574375C (en) | 2004-07-23 | 2015-03-17 | Chiron Srl | Polypeptides for oligomeric assembly of antigens |
| BRPI0514672A (pt) * | 2004-08-25 | 2008-06-17 | Epitopix Llc | polipeptìdeos de fusobacterium e métodos de uso |
| EP1848732B1 (en) * | 2005-01-21 | 2016-07-27 | Epitopix, LLC | Yersinia spp. polypeptides and methods of use |
| NZ599345A (en) * | 2005-02-18 | 2013-07-26 | Novartis Vaccines & Diagnostic | Immunogens from uropathogenic Escherichia Coli |
| WO2006113907A2 (en) * | 2005-04-20 | 2006-10-26 | The General Hospital Corporation | Escherichia coli o157:h7 proteins and uses thereof |
-
2006
- 2006-01-20 EP EP06719369.8A patent/EP1848732B1/en active Active
- 2006-01-20 BR BRPI0606506-6A patent/BRPI0606506A2/pt not_active Application Discontinuation
- 2006-01-20 NZ NZ556651A patent/NZ556651A/en not_active IP Right Cessation
- 2006-01-20 CN CNA2006800028566A patent/CN101142230A/zh active Pending
- 2006-01-20 MX MX2007008723A patent/MX2007008723A/es active IP Right Grant
- 2006-01-20 EP EP11075020A patent/EP2361926A3/en not_active Withdrawn
- 2006-01-20 AU AU2006206234A patent/AU2006206234B2/en not_active Ceased
- 2006-01-20 US US11/336,706 patent/US8563004B2/en active Active
- 2006-01-20 WO PCT/US2006/002474 patent/WO2006079076A2/en not_active Ceased
- 2006-01-20 JP JP2007552375A patent/JP2008528512A/ja not_active Withdrawn
- 2006-01-20 CA CA002595163A patent/CA2595163A1/en not_active Abandoned
- 2006-01-20 EP EP11007570A patent/EP2431382A1/en not_active Withdrawn
- 2006-01-20 ES ES06719369.8T patent/ES2588010T3/es active Active
- 2006-01-20 DK DK06719369.8T patent/DK1848732T3/en active
-
2011
- 2011-01-31 US US13/018,292 patent/US20110206674A1/en not_active Abandoned
-
2012
- 2012-09-24 JP JP2012209231A patent/JP6178059B2/ja active Active
-
2013
- 2013-10-08 US US14/048,643 patent/US9109018B2/en active Active
- 2013-10-08 US US14/048,649 patent/US9085613B2/en active Active
- 2013-10-08 US US14/048,640 patent/US9085612B2/en active Active
-
2015
- 2015-07-07 US US14/793,494 patent/US9221899B2/en active Active
- 2015-07-10 JP JP2015139060A patent/JP6224655B2/ja active Active
- 2015-11-05 US US14/933,899 patent/US9352029B2/en active Active
-
2016
- 2016-04-28 US US15/140,767 patent/US9801932B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2007008723A (es) | Polipeptidos de yersinia spp y metodos de uso. | |
| TW200732349A (en) | Anti-OX40L antibodies and methods using same | |
| MX2010004374A (es) | Armazones proteinicos. | |
| MX2010006738A (es) | Inhibidores de proteasa del virus de la hepatitis c (hcv) y usos de los mismos. | |
| MX2010006736A (es) | Inhibidores de proteasa del virus de la hepatitis c (hcv) y usos de los mismos. | |
| WO2008121767A3 (en) | Stitched polypeptides | |
| MY152503A (en) | 4-phenyl-pyrane-3, 5-diones, 4-phenyl-thiopyrane-3, 5-diones and cyclohexanetriones as novel herbicides | |
| MX341370B (es) | Antagonistas anti - beta7 humanizados y usos para los mismos. | |
| WO2008060705A8 (en) | Anti-dll4 antibodies and methods using same | |
| GB2430677A8 (en) | Novel antigenbinding polypeptides and their uses | |
| MX286273B (es) | Composiciones y metodos para inhibicion de la via jak. | |
| UA101346C2 (ru) | 4-фенилпиран-3,5-дионы, 4-фенилтиопиран-3,5-дионы и 2-фенилциклогексан-1,3,5-трионы как гербициды | |
| TNSN07196A1 (en) | Potentiators of glutamate receptors | |
| TW200608973A (en) | Rapamycin polymorph Ⅱ and uses thereof | |
| WO2010077740A3 (en) | Novel antiviral compounds, compositions, and methods of use | |
| WO2009042114A3 (en) | Phenazine derivatives and uses thereof | |
| WO2007130697A8 (en) | Anti-ephb4 antibodies and methods using same | |
| TW200738751A (en) | Anti-EphrinB2 antibodies and methods using same | |
| WO2006088803A3 (en) | Polypeptides from staphylococcus aureus and methods of use | |
| TN2010000045A1 (en) | Novel herbicides | |
| TW200800967A (en) | Benzimidazole thiophene compounds | |
| TW200727920A (en) | New regimens for oral monophasic contraceptives | |
| MX339461B (es) | Polipeptidos y composiciones inmunizantes que contienen polipeptidos grampositivos y metodos de uso. | |
| WO2005087793A3 (en) | Immunostimulatory compositions and uses thereof | |
| PL1677818T3 (pl) | Stabilne kompozycje wodne zawierające G-CSF |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |